Background {#Sec1}
==========

Pulmonary tuberculosis (PTB) is one of the serious infectious diseases with high mortality in the world. PTB is caused by various strains of mycobacteria with *Mycobacterium tuberculosis* (Mtb) being mostly observed in human. According to the World Health Organization (WHO) report, there were 10 million new cases of PTB disease and 1.5 million deaths worldwide in 2017 (WHO, 2018). It has been estimated that one third of the world's population are infected with Mtb as latent infections, among which 5 to 10% would develop into active tuberculosis (TB) \[[@CR1], [@CR2]\]. Quick diagnostic and efficient treatment are of great importance to control the spread of PTB and reduce its mortality \[[@CR3], [@CR4]\]. Despite accumulating evidence on the mechanism of PTB, the molecular processes and the specific gene regulations in the progression of PTB remain to be explored.

Omics approaches, like genomics, transcriptomics, proteomics and metabolomics, are high-throughput methods that provide an opportunity to investigate the global gene expression changes in PTB \[[@CR3]\]. Transcriptome profiling based on microarray or next-generation sequencing has been widely used for differentially expressed genes (DEGs) screening in human diseases. With the application of genechips, a large amount of data has been produced, most of which have been deposited in public databases. Integrating and re-analyzing these data provide valuable clues to advance our researches. In recently years, many microarray data profiling studies have been performed on PTB \[[@CR5]\]. Through bioinformatic analysis, a number of DEGs and functional pathways have been identified \[[@CR6]\]. However, these results are either inconsistent due to sample heterogeneity in individual studies, or limited by a single cohort study. So far, no reliable biomarkers are available for PTB diagnostics. Integrated bioinformatic analysis by combining these expression profiling data together would be a powerful approach to solve the disadvantages.

Here we analyzed two microarray datasets GSE34608 and GSE83456 from human whole blood samples including 53 health controls and 79 PTB samples. Multiple bioinformatics methods were employed to identify DEGs between the two datasets. Gene Ontology, pathway enrichment, Protein-Protein Interaction (PPI) network construction were performed to reveal the function of hub genes in PTB. Findings of this study might help to explore essential diagnostic signatures for PTB and shed a light on the molecular targets to treat PTB.

Methods {#Sec2}
=======

Gene expression microarray data acquisition {#Sec3}
-------------------------------------------

NCBI Gene Expression Omnibus database (GEO, <http://www.ncbi.nlm.nih.gov/geo>) is a public functional genomics database with high throughput gene expression sequencing data and microarrays data. Two gene expression datasets GSE34608 \[[@CR7]\] and GSE83456 \[[@CR6]\], were downloaded from GEO. GSE34608 contained 8 PTB samples and 18 control samples, which is based on GPL6480 platform (Agilent-014850 Whole Human Genome Microarray 4x44K G4112F). The GSE83456 dataset contained 45 PTB tissue samples and 61 control samples. It is based on GPL10558 platform (Illumina HumanHT-12 V4.0 expression beadchip). Another two datasets GSE19439 and GSE31348 were used for hub gene validation. GSE19439 contained 12 health and 13 PTB samples were used as validation dataset \[[@CR8]\]. GSE19439 is based on GPL6947 platform (Illumina HumanHT-12 V3.0 expression beadchip). GSE31348 contained 27 subjects (135 samples) in five time point: diagnosis, treatment for 1, 2, 4 and 26 weeks, which is based on GPL570 platform (Affymetrix Human Genome U133 Plus 2.0 Array) \[[@CR9]\].

Identification of DEGs {#Sec4}
----------------------

Based on the microarray platform annotation, probe sets were converted into the corresponding gene symbol for the following analysis. Probe sets without corresponding gene symbols were removed. The DEGs between control and PTB samples were analyzed using limma (linear models for microarray data) package in R. \|log2FC (fold change)\| \> 1 and adj. *P*-value \< 0.05 were considered as statistically significant threshold for the DEGs selection of GSE34608. \|log2FC\| \> 0.585 and adj. P-value \< 0.05 were considered as statistically significant threshold for the DEGs selection of GSE83456. The co-existed DEGs were identified by drawing the venn diagram of DEGs of GSE34608 and GSE83456.

KEGG and GO enrichment analyses of DEGs {#Sec5}
---------------------------------------

Metascape (a gene annotation & analysis resource; <http://metascape.org/>) is online gene functional annotation tool to provide a comprehensive set of biological information of genes and proteins \[[@CR10]\]. To understand the function of DEGs, Gene Oncology (GO) analysis, including biological process (BP), cellular components (CC), molecular function (MF), and KEGG pathway enrichment were performed using Metascape.

PPI network construction and module analysis {#Sec6}
--------------------------------------------

In the present study, the PPI network was predicted using the Search Tool for the Retrieval of Interacting Genes (STRING; <http://string-db.org>) (version 11.0) online database \[[@CR11]\]. The cut off value for STRING analysis is 0.04. Analyzing the functional interactions between proteins may provide insights into the biological mechanisms of action. PPI network were further visualized and analyzed with Cytoscape (version 3.4.0) plug-in APP Molecular Complex Detection (MCODE), which is used for clustering a given network based on topology. The most critical modules in the PPI network could be identified. The genes in top one module was displayed in this study. The hub gene selection criteria were as follows: MCODE scores \> 10, degree \> 20, neighborhood connectivity \> 10.

Hub genes analysis {#Sec7}
------------------

The GO function, pathway, and protein domains of the top module were analyzed using STRING. The expression levels of hub genes were further validated in datasets GSE19439 and GSE31348.

Results {#Sec8}
=======

Identification of DEGs {#Sec9}
----------------------

Gene expression profile of GSE34608 and GSE83456 were downloaded from GEO database. The microarray data GSE34608 contains 18 control and 8 PTB patients. The GSE83456 data contains 61 control samples and 45 PTB samples. PCA plots of both datasets indicated the distinction expression of control and PTB samples (Fig. [1](#Fig1){ref-type="fig"}a and b). 2214 and 1025 DEGs were identified from GSE34608 and GSE83456 datasets, respectively (Fig. [2](#Fig2){ref-type="fig"}a). Venn diagram demonstrated that, among the 180 shared DEGs, 51 genes were down-regulated and 129 genes were upregulated in both datasets (Fig. [2](#Fig2){ref-type="fig"}a). Fig. 1Principal component analysis (PCA) to discriminate the gene expression levels between control and pulmonary tuberculosis (PTB). **a** PCA plot of dataset GSE34608. **b** PCA plot of dataset GSE83456Fig. 2Selection and function of differentially expressed genes (DEGs). **a** Venn diagram of DEGs from the two datasets: GSE19439 and GSE34608. Totally 51 down-regulated and 129 up-regulated genes are shared between the two GSE datasets. **b** and **c** Functional annotation of DEGs using Metascape. The top 20 terms are displayed as bar plot based on *P* value (log10 scale) (**b**), and the network plot (**c**)

GO enrichment and KEGG pathway analyses {#Sec10}
---------------------------------------

Candidate DEGs functional Gene Ontology (GO) and pathway enrichment analyses were performed with Metascape. The results showed that DEGs were significantly enriched in defense response to other organism, response to bacterium, myeloid leukocyte activation, cytokine production, positive regulation of defense responses, cytokine-mediated signaling pathway, interferon signaling, etc. (Fig. [2](#Fig2){ref-type="fig"}b).

The subset of representative terms of gene function analysis were converted into a network layout in Metascape, as shown in Fig. [2](#Fig2){ref-type="fig"}c. Based on gene function analysis, all the significant terms were hierarchically clustered into a tree based on Kappa-statistical similarities. Each term is represented by a circle node, where its size is proportional to the number of input genes fall into that term. The color represents its cluster identity (Fig. [2](#Fig2){ref-type="fig"}c). Terms with a kappa score \> 0.3 are linked by an edge. The statistically significant range of the node is marked by color range (Fig. [2](#Fig2){ref-type="fig"}c).

PPI network construction and module analysis {#Sec11}
--------------------------------------------

The PPI network of 180 DEGs was constructed using the STRING online database, and further analyzed using app MCODE in Cytoscape software. Totally, seven modules were identified shown in Table [1](#Tab1){ref-type="table"}. Module 1 from the PPI network complex contained 35 genes, indicating the core functional gene panel. GO analysis of 35 genes showed that their functions are related to defense response and cytokine related pathway (Fig. [3](#Fig3){ref-type="fig"}a). PPI network of module 1 was redrawn by STRING (Fig. [3](#Fig3){ref-type="fig"}b). The expression level of 35 genes in dataset GSE34608 were shown in Fig. [3](#Fig3){ref-type="fig"}c. Genes CD27, CCR7, CD19, and CXCR3 were significantly down-regulated in PTB samples, where other genes were upregulated. This result was consistent with the gene expression levels in GSE83456 (Fig. [3](#Fig3){ref-type="fig"}d). Furthermore, function analysis from STRING database were shown in Table [2](#Tab2){ref-type="table"}. GO function was significantly related to defense response and immune system response (biological process function), chemokine binding and chemokine receptor activity (molecular function), and external side of plasma membrane and cell surface (cellular component). KEGG and Reactome pathways indicated that these 35 genes were involved in cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, immune system, and cytokine signaling in immune system. TIR domain, leucine rich repeat, and chemokine receptor family were the three important features revealed by PFAM and INTERPRO protein domains analysis (Table [2](#Tab2){ref-type="table"}). Table 1Seven modules were identified by MCODE based on the 180 DEGsModuleGene symbolModule 1TLR2 IL1B TLR8 TLR1 IFIH1 TLR5 IFIT1 CD19 IFIT2 CCR7 MPO CXCR3 IFI44 DDX60 FCGR2A CD163 IFI44L GBP2 TNFSF10 CD274 CCR2 XAF1 IFI16 IFITM1 IDO1 HERC5 SAMD9L EIF2AK2 RTP4 CCR1 CD27 PLSCR1 TNFSF13B PARP9 EPSTI1Module 2CXCL10 GBP5 ELANE AIM2 LCN2 DEFA4 HP NLRC4 MMP8 LTF TCN1 HPSEModule 3STAT1 LCK FASModule 4CEACAM1 GPR84 BST1Module 5FAM26F SPPL2A USP25Module 6DBP TLE2 AESModule 7CAMP CEACAM8 S100A12 RNASE3Fig. 3Functional analysis of 35 genes in Module 1. **a** GO analysis reveals that genes functionally related to defense response to other organism underlie PTB infection. **b** Network of Module 1 genes constructed by STRING. **c** Heatmap showing the gene expression of module 1 in individuals from dataset GSE34608. **d** Heatmap showing the gene expression of module 1 in individuals from dataset GSE83456. Each row represents a gene, and each column represents a sampleTable 2Function analysis of the 35 genes in module 1TermDescriptionCountFDR**Biological Process (GO)** GO:0006952Defense response28 of 12342.39E-24 GO:0002376Immune system process31 of 23701.2E-21 GO:0051707Response to other organism22 of 8354.56E-19 GO:0006955Immune response25 of 15609.48E-18 GO:0002682Regulation of immune system process24 of 13911.52E-17**Molecular Function (GO)** GO:0019956Chemokine binding4 of 220.0000233 GO:0004950Chemokine receptor activity4 of 270.0000243 GO:0019957C-C chemokine binding3 of 110.000088 GO:0016493C-C chemokine receptor activity3 of 130.00011 GO:0003725Double-stranded RNA binding4 of 700.00028**Cellular Component (GO)** GO:0009897External side of plasma membrane9 of 2232.93E-08 GO:0009986Cell surface11 of 6900.0000015 GO:0035354Toll-like receptor 1-Toll-like receptor 2 protein complex2 of 20.00064 GO:0005887Integral component of plasma membrane11 of 15640.0017 GO:0044459Plasma membrane part13 of 26510.0083**KEGG Pathways** hsa04060Cytokine-cytokine receptor interaction8 of 2630.00000133 hsa04620Toll-like receptor signaling pathway5 of 1020.0000409 hsa05162Measles5 of 1330.0000955 hsa05168Herpes simplex infection5 of 1810.00031 hsa05134Legionellosis3 of 540.0019**Reactome Pathways** HSA-168256Immune system22 of 19253.84E-12 HSA-1280215Cytokine signaling in immune system12 of 6545.29E-08 HSA-913531Interferon signaling7 of 1890.00000192 HSA-168249Innate immune system12 of 10120.0000032 HSA-909733Interferon alpha/beta signaling5 of 660.0000039**PFAM Protein Domains** PF01582TIR domain4 of 220.0000057 PF13855Leucine rich repeat4 of 1870.0051 PF13676TIR domain2 of 110.0051 PF13306Leucine rich repeats (6 copies)3 of 880.0051 PF01463Leucine rich repeat C-terminal domain2 of 120.0051**INTERPRO Protein Domains and Features** IPR035897TIR domain superfamily4 of 260.00000766 IPR000355Chemokine receptor family4 of 210.00000766 IPR000157TIR domain4 of 220.00000766 IPR024644Interferon-induced protein 44 family2 of 20.00031 IPR000483Cysteine-rich flanking region, C-terminal4 of 830.00031

Hub genes analysis {#Sec12}
------------------

A total of 14 genes were selected as hub genes based on criteria MCODE (scores \> 10, degree \> 20, neighborhood connectivity \> 10) in Table [3](#Tab3){ref-type="table"}. All the hub genes were belonging to the module 1. These hub genes were significantly associated with Toll-like receptors, interferon-induce proteins, and chemokine receptors (Table [3](#Tab3){ref-type="table"}). Among them, two genes were upregulated, whereas others were downregulated (Fig. [3](#Fig3){ref-type="fig"}c). The expression levels were further validated in dataset GSE19439 (Fig. [4](#Fig4){ref-type="fig"}). The expression levels were also significantly different between health and PTB patients, except gene CD19 and CXCR3 (Fig. [4](#Fig4){ref-type="fig"}). Table 3The functions of 14 hub genesGeneScore^a^Full nameFunction^b^CD16312Scavenger receptor cysteine-rich type 1 protein M130Acute phase-regulated receptor involved in clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages and may thereby protect tissues from free hemoglobin-mediated oxidative damage.TLR511.02941Toll-like receptor 5Participates in the innate immune response to microbial agents.IFIT110.82353Interferon-induced protein with tetratricopeptide repeats 1Interferon-induced antiviral RNA-binding protein that specifically binds single-stranded RNA bearing a 5′-triphosphate group (PPP-RNA), thereby acting as a sensor of viral single- stranded RNAs and inhibiting expression of viral messenger RNAs.IFIT210.82353Interferon-induced protein with tetratricopeptide repeats 2IFN-induced antiviral protein which inhibits expression of viral messenger RNAs lacking 2′-O-methylation of the 5′ cap.CCR710.7451C-C chemokine receptor type 7Receptor for the MIP-3-beta chemokine. Belongs to the G-protein coupled receptor 1 family.CXCR311.2C-X-C chemokine receptor type 3Isoform 1- Receptor for the C-X-C chemokine CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of human mesangial cells (HMC) through a heterotrimeric G-protein signaling pathway.TLR110.7451Toll-like receptor 1Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides.FCGR2A10.63736Low affinity immunoglobulin gamma Fc region receptor II-aBinds to the Fc region of immunoglobulins gamma.CD1910.7451B-lymphocyte antigen CD19Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.IFIH110.82353Interferon-induced helicase C domain-containing protein 1Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines.IFI44L10.82353Interferon-induced protein 44-likeExhibits a low antiviral activity against hepatitis C virus.TLR810.7451Toll-like receptor 8Key component of innate and adaptive immunity.IFI4410.82353Interferon-induced protein 44This protein aggregates to form microtubular structures.TLR210.7451Toll-like receptor 2Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components.Score^a^: indicated MCODE score. Function^b^: obtained from NCBI (<https://www.ncbi.nlm.nih.gov/>)Fig. 4Expression validation of the hub genes in dataset GSE19439. **a-n** Demonstrate the expression of IFIH1, IFI44L, IFI44, IFITI, IFIT2, TLR1, TLR2, TLR5, TLR8, FCCGR2A, CD163, CCR7, CD19, CXCR3 during PTB infection, respectively. \*\**P* value \< 0.01; \*\*\**P* value \< 0.001; ns indicates not significant

Gene expression level detection during PTB treatment {#Sec13}
----------------------------------------------------

To figure out the expression level changes during PTB treatment process, dataset GSE31348 were used to evaluate the change level. GSE31348 contained the 27 PTB patients, including 135 samples from 5 time points. Heatmap showed that the expression level of genes related with the functions (Fig. [5](#Fig5){ref-type="fig"}a). The expression level of CCR7, CD19, and CXCR3 were significantly increased, whereas the expression level of Interferon-induced proteins, Toll-like receptors were decreased during the treatment (Fig. [5](#Fig5){ref-type="fig"}a). Among these 14 genes, the expression level of CXCR3 were significantly increased, and TLR2 and TLR5 were significantly decreased during the PTB treatment (Fig. [5](#Fig5){ref-type="fig"}b). These three genes might have a potential to evaluate PTB as a gene panel. Fig. 5The expression levels of hub genes during PTB treatment in five time points in dataset GSE31348. Heatmap (**a**) and box plot (**b**) of hub genes in dataset GSE31348. The central of rectangle indicates the medium. The ends of the whiskers represent the first quartile to the third quartile (the interquartile range or IQR). The ends of central line show the minimum or maximum value. \**P* value \< 0.05; \*\**P* value \< 0.01; \*\*\**P* value \< 0.001; ns indicates not significant

Discussion {#Sec14}
==========

In this study, we analyzed two GEO datasets GSE34608 and GSE83456 to identify hub genes related to PTB disease. Totally, 180 DEGs were identified by combining these two GEO datasets (Fig. [2](#Fig2){ref-type="fig"}). With STRING protein-protein interaction data, 14 hub genes were identified (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). The function of these 14 hub genes were chemokine receptors, interferon-induced proteins and Toll-like receptors (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). The signature of hub genes are significantly correlated with PTB infection as well as anti-PTB therapy (Fig. [5](#Fig5){ref-type="fig"}).

Our study reveals the core genes in response to Mtb infection. The gene expression profile in PTB patients conforms to the common inflammatory responses upon viral and bacterial infections \[[@CR12]\]. Chemokine receptors, interferon-induced proteins, and Toll-like receptors were involved in this core response profiling, and significantly changed following successful treatment.

Chemokines play a major role in the host response to Mtb infection as they contribute to the formation and maintenance of quiescent granulomas and the establishment of the TB granuloma. High concentrations of cytokines and chemokines are required for early protection against Mtb infections, but may also be involved in the over-response of host immune system \[[@CR13]\]. Plasma cytokines can serve as biomarkers for the disease severity, and function to relieve the mycobacterial burden in PTB disease \[[@CR14]\]. Consistent with our analyses, a previous study has reported that PTB patients displayed significantly elevated levels of CCL1, CCL3, CXCL1, CXCL10 and CXCL11 which were significantly reduced following successful treatment \[[@CR14]\].

Type I interferon response pathway is a well-established pathway crucial for the defense against viral pathogens, but it could also be detrimental upon infection with mycobacteria \[[@CR15]\]. Although the signaling axis through this pathway is identical regardless of the type of infection, the outcome is substantially different, suggesting that the type I IFNs and the related IFN-inducible genes are able to create a favorable or unfavorable intracellular milieu to promote or disrupt the survival of invading pathogens \[[@CR16]\]. Changes in mRNA levels of IFIT1, IFIT2, CXCR3 and CD163 have been validated by qPCR in previous studies \[[@CR17]--[@CR19]\]. Moreover, Kim et al. \[[@CR20]\] confirmed that five genes (IFN-γ, TNF-α, IL-2R, CXCL9, and CXCL10) could be used for the detection of Mtb infection, including active PTB disease and LTB with sensitivity of each gene above 80%. The gene panel revealed in this study provides a more comprehensive network for selecting diagnostic biomarkers. However, it needs to be further tested in other infectious diseases to figure out the transcriptional signature specific to PTB disease or shared with other types of infections.

The essential role of Toll-like receptors against mycobacterial infection has been revealed in vivo. Toll-like receptors play key roles in innate and adaptive immunity against Mtb, and are involved in the recognition of conserved microbial structures, leading to activation of an inflammatory response. Previous study showed that TLR3 and TLR5 were upregulated at 24, 48 and 72 h post-infection in A549 pulmonary epithelial cells treated with Mtb \[[@CR21]\], and the expression of neutrophil TLR2 is also increased in PTB patients \[[@CR22]\]. Whole blood from patients had increased mRNA levels of TLR1 and TLR2 \[[@CR23]\]. TLR2-deficient mice showed increased subsequent progression to PTB disease, the rapid death and higher Mtb burden \[[@CR24]\]. TLR2 may function as a regulator of inflammation, and its absence exacerbated the detrimental inflammatory response. TLR1 rs5743551 and rs5743618 polymorphisms significantly increased under the Mtb infection in 203 PTB patients, compared to 203 healthy subjects \[[@CR24]\]. TLR8 polymorphisms rs3764879 and rs3764880 have also been reported to cause differential sensitivity to Mtb infection by specific strains \[[@CR25]\].

Gene function can be regulated at multiple levels. Integrated multi-omics analysis provides a better approach to understand the comprehensive biological processes in human diseases. By integrating transcriptomics, proteomics and metabolomics, Zhao et al. \[[@CR26]\] revealed the molecular link between lipid metabolism and inflammatory response in chronic obstructive pulmonary disease (COPD) treated with a Chinese medicine Bufei Jianpi Formula in a rat model. Similar strategies were also applied to study the Laser Printer-Emitted Nanoparticles (PEPs) inhalation exposure-induced disease risks to identify metabolite biomarkers \[[@CR27]\]. In Mtb research, metabolomics has been applied to investigate the metabolic traits in Mtb species \[[@CR28], [@CR29]\]. However, omics study other than transcriptomics in the host system under Mtb infection is limited. Changes in host proteome and metabolome after Mtb infection need to be further investigated to provide a more detailed landscape to understand the molecular mechanism of PTB disease.

Conclusion {#Sec15}
==========

In summary, we construct a refined gene network representing the transcriptome signature in response to Mtb infection and its treatment. The identified 14 hub genes are promising biomarkers for developing transcriptome-based PTB diagnostic or prognostic tests. As major regulators of the host immune response to Mtb infection, these genes are also potential molecular targets for developing drugs to treat PTB.
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